X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ACTAVIS (US) - Comparison Results

PROCTER & GAMBLE HEALTH    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   ACTAVIS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
ACTAVIS
Dec-18
PROCTER & GAMBLE HEALTH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,35813,286-   
Low Rs9338,912-   
Sales per share (Unadj.) Rs665.03,259.0-  
Earnings per share (Unadj.) Rs56.6-1,049.7-  
Cash flow per share (Unadj.) Rs72.5343.4-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.713,441.8-  
Shares outstanding (eoy) m16.60332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.4 50.6%   
Avg P/E ratio x20.2-10.6 -191.5%  
P/CF ratio (eoy) x15.832.3 48.9%  
Price / Book Value ratio x2.60.8 314.0%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0113,691,490 0.5%   
No. of employees `0001.516.9 9.1%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.064,138.2 11.1%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.2-20,658.9 -2.9%   
INCOME DATA
Net Sales Rs m11,0401,083,935 1.0%  
Other income Rs m24020,728 1.2%   
Total revenues Rs m11,2791,104,664 1.0%   
Gross profit Rs m1,37628,405 4.8%  
Depreciation Rs m264463,359 0.1%   
Interest Rs m062,549 0.0%   
Profit before tax Rs m1,352-476,775 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170121,597 0.1%   
Tax Rs m583-6,042 -9.6%   
Profit after tax Rs m939-349,136 -0.3%  
Gross profit margin %12.52.6 475.7%  
Effective tax rate %43.11.3 3,401.7%   
Net profit margin %8.5-32.2 -26.4%  
BALANCE SHEET DATA
Current assets Rs m7,523444,574 1.7%   
Current liabilities Rs m2,253393,284 0.6%   
Net working cap to sales %47.74.7 1,009.0%  
Current ratio x3.31.1 295.5%  
Inventory Days Days5220 266.3%  
Debtors Days Days4166 61.2%  
Net fixed assets Rs m1,240122,695 1.0%   
Share capital Rs m1660-   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,3334,470,727 0.2%   
Long term debt Rs m01,574,305 0.0%   
Total assets Rs m9,9126,988,764 0.1%  
Interest coverage xNM-6.6-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.2 718.1%   
Return on assets %9.5-4.1 -231.0%  
Return on equity %12.8-7.8 -164.0%  
Return on capital %20.8-4.8 -428.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m537387,249 0.1%  
From Investments Rs m-476212,743 -0.2%  
From Financial Activity Rs m-220-664,636 0.0%  
Net Cashflow Rs m-160-64,321 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.66 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PROCTER & GAMBLE HEALTH With: PANACEA BIOTECH  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Easing of WPI Inflation; Key Q1FY20 Results; Global Stock Market Drivers and Top Stocks in Action(Pre-Open)

On Monday, the Indian share markets ended in the positive territory. The BSE Sensex settled 160 points higher at 38,897 levels with Infosys, Sun Pharma, Tech Mahindra and Maruti being the top gainers.

Related Views On News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today (Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance (The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 16, 2019 09:25 AM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS